![Tamar Tennenbaum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tamar Tennenbaum
No más puestos en curso
Historial de carrera de Tamar Tennenbaum
Antiguos cargos conocidos de Tamar Tennenbaum.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
HealOr Ltd.
![]() HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Fundador | 30/03/2010 | - |
Presidente | 01/01/2002 | - |
Formación de Tamar Tennenbaum.
The Hebrew University of Jerusalem | Doctorate Degree |
Estadísticas
Internacional
Israel | 3 |
Operativa
Founder | 1 |
President | 1 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
HealOr Ltd.
![]() HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Tamar Tennenbaum
- Experiencia